Previous Article | Next Article ![]()
J. Virol., Sep 1995, 5475-5484, Vol 69, No. 9
D Peng, CA Koetzner, T McMahon, Y Zhu and PS Masters
Targeted RNA recombination was used to construct mouse hepatitis virus
(MHV) mutants containing chimeric nucleocapsid (N) protein genes in which
segments of the bovine coronavirus N gene were substituted in place of
their corresponding MHV sequences. This defined portions of the two N
proteins that, despite evolutionary divergence, have remained functionally
equivalent. These regions included most of the centrally located
RNA-binding domain and two putative spacers that link the three domains of
the N protein. By contrast, the amino terminus of N, the acidic
carboxy-terminal domain, and a serine- and arginine-rich segment of the
central domain could not be transferred from bovine coronavirus to MHV,
presumably because these parts of the molecule participate in
protein-protein interactions that are specific for each virus (or,
possibly, each host). Our results demonstrate that targeted recombination
can be used to make extensive substitutions in the coronavirus genome and
can generate recombinants that could not otherwise be made between two
viruses separated by a species barrier. The implications of these findings
for N protein structure and function as well as for coronavirus RNA
recombination are discussed.
Copyright © 1995, American Society for Microbiology
Construction of murine coronavirus mutants containing interspecies chimeric nucleocapsid proteins
Department of Biomedical Sciences, State University of New York at Albany, New York, USA.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|